$CNK

Bedard Caren sold (to issuer) $242K of CNK

Bedard Caren (SVP-Global Controller) sold (to issuer) 8,000 shares of Cinemark Holdings, Inc. (CNK) at $30.23 ($0.24M total) on 2026-06-04.

Original reporting
SEC EDGAR · Bedard Caren
Published Jun 8, 2026, 8:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNK
Neutral
medium confidence
Mentioned
$CNK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosure updates the record of an officer’s holdings after a sale to the issuer; it does not include guidance, litigation, or operational changes.

02

Market read

Traders may note the insider transaction for sentiment/flow monitoring, but there is no new fundamental catalyst in the text.

03

What to watch

The article doesn’t state whether the sale was part of a broader repurchase/employee liquidity mechanism beyond the 'sale to issuer' code; without that context, directional inference is weak.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-08 (covers sale dated 2026-06-04).

Background

The article is an SEC Form 4 insider transaction filing for Cinemark Holdings, Inc.

Company-level read

Ticker impact

$CNKNeutralMedium confidence
Context

Cinemark insider Bedard Caren (SVP-Global Controller) sold 8,000 shares to the issuer at $30.23 on 2026-06-04 via Form 4.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

Form 4 insider transactions are typically low-signal unless tied to unusual size, pattern, or accompanying corporate news; this filing provides transaction details but no new company catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

If the sale is tied to a company buyback program, it may reflect planned liquidity/administration rather than bearish insider conviction.

Key entities

  • Cinemark Holdings, Inc.

    CNK; subject of the Form 4 insider transaction disclosure.

  • Bedard Caren

    SVP-Global Controller who sold 8,000 shares to the issuer.

Related articles

$CNKMed

Cinemark Holdings, Inc. (CNK): Results of Operations and Financial Condition

Cinemark Holdings, Inc. (CNK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cnk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Generated all-time high quarterly revenue of $1.1 billion with records across all major revenue categories Delivered Net Income of $141 million, an increase of nearly

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.

$TSCOMed

Tractor Supply downgrade, Five Below upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes across retail, software, media, telecom infrastructure, and industrials. Mizuho downgraded Tractor Supply (TSCO) to Neutral, cutting its FY26 outlook, while upgrading Five Below (FIVE) to Outperform with a $220 target. Goldman upgraded Toast (TOST) to Buy ($36), and other firms adjusted targets for Sarepta (SRPT), Cinemark (CNK), American Tower (AMT), and more.